Aptiv Solutions Release: Tufts Center for the Study of Drug Development Study Finds Adoption of Adaptive Clinical Trial Designs Is Increasing

Published: May 23, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

RESTON, Va.--(BUSINESS WIRE)--Aptiv Solutions, a biopharmaceutical and medical device development services company and pioneer in adaptive clinical trial design, simulation and execution, announces publication of a Tufts Center for the Study of Drug Development (CSDD) report on the adoption and impact of adaptive trial designs.

Help employers find you! Check out all the jobs and post your resume.

Back to news